Patent · US Active

Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate

US9107840B2 · kind B2 · utility

0Cited by

6References

5Claims

0Family size

Assignee

RICHTER GEDEON NYRT. · HU

Inventors

Georg Schramm · Stolberg, DE
Rainer Henske · Essen, DE

Key dates

Filing date	Dec 10, 2004
Grant date	Aug 18, 2015
Priority date	—
Expiry date	Jan 19, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P17/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a hormonal contraceptive including at least 120 hormone-containing daily units, which contain 5 to 50 μg of ethinyloestradiol and 1 to 5 mg of chlormadinone acetate, and optionally 7 to 3 hormone-free daily units for uninterrupted oral administration to women.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.